InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Dorling Janet. Officer active across 1 company, notably CymaBay Therapeutics, Inc.. In total, 4 reports have been logged. Activity tracked since 10 November 2023. The latest transaction was filed on 12 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations